Zika vaccine: Inovio starts clinical study in Puerto Rico
by Press Release from Outbreak News Today on (#1S0VG)
Inovio Pharmaceuticals, Inc. today announced it has initiated a clinical study of its preventive Zika vaccine (GLS-5700) in 160 subjects in Puerto Rico, where the Zika virus outbreak has been declared a public health emergency. The CDC estimates Zika will infect more than 25% of the Puerto Rican population by year end, providing the potential ["]
